CLINICAL_TRIALS
trial_result
· 2020-02-17
Clinical Trial Update: Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating manganese-enhanced MRI (MEMRI) to assess peri-infarct injury in ischemic cardiomyopathy has completed with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: ISCHEMIC CARDIOMYOPATHY | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-17